Synergistic Effects of the Combination of Alpelisib (PI3K Inhibitor) and Ribociclib (CDK4/6 Inhibitor) in Preclinical Colorectal Cancer Models. - Aslam, Razia; Richards, Cathy E.; Fay, Joanna; Hudson, Lance; Workman, Julie; Lee, Cha Len; Murphy, Adrian; O'Neill, Brian; Toomey, Sinead; Hennessy, Bryan T. (International Journal of Molecular Sciences, 2024)